Helping Latinas access breast cancer care
Official title: Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care
Run by University of Illinois Chicago · NCT05483283 · Data updated 2026-11-12
This study is trying to help Latina women at higher risk for breast cancer by giving them personalized support and education over the phone about breast cancer care, diet, and exercise.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years and up |
| Sex | Women only |
| Enrollment | 600 (estimated) |
| Sponsor | University of Illinois Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | January 18, 2023 |
| Main results expected | September 2027 |
| Study ends | September 2027 |
| Registry record updated | March 10, 2026 |
| Trial ID | NCT05483283 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Latina women aged 30 and older with a genetic risk factor for breast cancer and a social determinant of health risk.
✕Probably not a fit
Patients who do not identify as Latina or who have already received genetic counseling or testing may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to empower Latina women at elevated genetic and social risk for breast cancer by providing them with personalized education and support. Participants will engage in three individual phone-based sessions over three weeks, focusing on breast cancer care, diet, and physical activity. The sessions will include testimonials and action plans to address disparities in breast cancer care uptake. Participants will also receive multimedia materials to reinforce the information shared during the sessions.
Why it matters
Potential benefit: If successful, this approach could significantly improve breast cancer care access and outcomes for vulnerable Latina women.
How similar studies have gone: Other studies have shown success in using empowerment and education to improve health outcomes in similar populations, indicating a promising approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Aim 1 1. female biological sex 2. identification as Latina 3. one genetic risk factor (i.e., personal history of breast cancer or family history of breast or ovarian cancer) 4. one SDH risk factor, based on the American Cancer Society's definitions (e.g., perceived financial struggles; transportation difficulties; exposure to violence; housing challenges; social isolation/challenges) 5. 30+ years old, based on American Cancer Society (ACS) screening guidelines for high risk populations 6. No receipt of cancer genetic counseling AND no receipt of genetic testing Aim 2 1. female biological sex 2. referral from Latina Aim 1 participants 3. eligibility to obtain BC screenings, based on ACS guidelines (e.g., optional annual 4. screenings at 40-44 years old, recommended annual screenings at 45-54 years old, every other year screening at 55 and older) 5. self-report not attending Session #3 (as this will not be recorded by the staff) Aim 3 1. participant from Aim 1 or 2. participant from Aim 2 Exclusion Criteria: Aim 1 and Aim 2 Not meeting at least one of the inclusion criteria Aim 3 1. Not a participant from Aim 1 or 2. Not a participant from Aim 2
Where it's running
-
University of Illinois
Chicago, Illinois, United States Recruiting
Study contacts
- Study coordinator: Yamile Molina, PhD
- Email: ymolin2@uic.edu
- Phone: 312-355-2679
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.